1MED today announces that LB Research is now part of the 1MED Group. Established in 2007 and based in Como, Italy, LB Research is a full-service contract research organisation providing clinical trial management across all clinical product life cycle phases.
LB Research operates with a highly skilled team of 24 professionals and maintains a diverse client portfolio, including well established global and Italian pharmaceutical companies. The addition of LB’s expertise will enhance 1MED’s clinical service offerings for pharmaceutical and medical device trials alike.
With extensive experience in clinical trial management across a variety of therapeutic areas, LB Research has developed a particularly strong track record in oncology studies, providing complementary expertise to 1MED’s capabilities.
This integration marks a strategic step forward in expanding 1MED’s clinical operations and strengthening its foothold in the European pharmaceutical and medical device markets.
Andrea Biffi, Chair of 1MED commented: “The addition of LB Research further enhances 1MED’s reputation as a trusted partner for the medtech and pharma community, advancing and promoting innovations, and improving patient outcomes globally.
It will provide us with an even stronger footprint in Italy and Southern Europe and reinforce some of the therapeutic areas we already operate in (cardiovascular / dermatology) while expanding our oncology capabilities.”
Flavio Lietti, Founder of LB Research said: “LB is excited to become part of the 1MED Group and looks forward to expanding its high-quality international solutions for clients in the medtech and pharma industry.”
Anne-Laure Meynier, Partner at Apposite Capital, added: “The addition of LB to the 1MED family is a significant move for us that in particular strengthens our clinical CRO services throughout Europe, further adding customizable solutions to the 1Med offering.”
Advising 1MED and Apposite on the transaction were Lexsential (legal) and Mazars (financial and tax).
Advising LB Research on the transaction were Marco Polo (corporate finance) and BLF (legal).
Media Contact:
Victoria O’Gorman
Tel: +44(0) 20 3475 1710
Email: victoria.ogorman@appositecapital.com
About Apposite Capital
Apposite Capital is an independent investment firm focused exclusively on healthcare. It focuses on companies operating in health and social care, medtech & medical products, pharmaceuticals & life science and digital health.
The firm operates at the lower end of the private equity market, providing both capital and expertise to those businesses offering ‘disruptive’ models that aim to improve or reduce the cost of care provision and which have the potential to become market leaders.
Apposite has an in-depth sector knowledge covering key aspects of the healthcare industry internationally coupled with local insights, an exceptional network and an entrepreneurial mindset which it applies to drive the growth of its portfolio companies.
About 1MED
1MED is a Contract Research Organization providing high-quality regulatory and clinical services to medical device, biotechnology and pharmaceutical companies.
1MED regulatory, quality and clinical services encompass all phases of the medical device development lifecycle, starting from device concept and preclinical phases, through clinical phases (first-in-human studies, pivotal studies) to post-market activities for certification maintenance (post-market surveillance and vigilance, post-market clinical follow-up, and real-world data collection).
1MED helps SMEs as well as larger companies face the complexity associated with the development of innovative medical devices in compliance with MDR by providing support from a strategic, regulatory, quality and clinical point of view. 1MED’s cross-functional approach has supported the certification and certification maintenance of more than 300 different medical devices.
1MED was established in 2014 and is headquartered in Agno, Switzerland.
About LB Research
Founded in 2007, LB Research is a full-service CRO with expertise in clinical trial management across multiple therapeutic areas. Known for its focus on Oncology and established partnerships with leading global and Italian pharmaceutical companies, LB Research delivers high-quality, compliant research services with a commitment to advancing healthcare innovations.